← Evidence map

ReviewDrugs2024

Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability.

Alise K Carlson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

52 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38480630